Immunovant, Inc. — Director's Dealing 2021

Sep 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2021-09-11

Reporting Person: Macias William L. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-11	Stock Option (right to buy)	$8.62	A	369320	Acquired	2031-06-11	Common Stock (369320.0)	Direct
2021-09-11	Stock Option (right to buy)	$10.71	D	369320	Disposed	2031-06-11	Common Stock (369320.0)	Direct

Footnotes

F1: Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on April 13, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.